Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ingersoll Rand Inc.IR · Entity 3152 | Director | February 26, 2025 | February 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ingersoll Rand Inc.
Report date February 26, 2025 · Filed February 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,792 |
Reported balance
After 2025-02-27 transaction · row 1
1 source rowRow 1 · 2025-02-27 · Exercise / conversion · Acquired 2,129 · Balance 2,792 F1: Represents restricted stock units originally granted on February 27, 2024, which vested on February 27, 2025 and upon vesting, were to be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,309 |
Reported balance
After 2025-02-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-26 · Grant · Acquired 2,309 · Balance 2,309 F2: These restricted stock units vest on February 26, 2026 and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-02-27 · Exercise / conversion · Disposed 2,129 · Balance 0 F1: Represents restricted stock units originally granted on February 27, 2024, which vested on February 27, 2025 and upon vesting, were to be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units originally granted on February 27, 2024, which vested on February 27, 2025 and upon vesting, were to be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.
F2: These restricted stock units vest on February 26, 2026 and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mativ Holdings, Inc.
Report date February 16, 2023 · Filed March 15, 2025
Section 16 reporting ended · disclosed 2025-03-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 227,478 |
Reported balance
After 2024-02-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-02-16 · Exercise / conversion · Acquired 16,038 · Balance 227,478 F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 211,440 |
Reported balance
After 2024-02-16 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2024-02-16 · Disposition to issuer · Disposed 16,038 · Balance 211,440 F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 313,356 |
Reported balance
After 2025-02-25 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2025-02-25 · Exercise / conversion · Acquired 113,916 · Balance 313,356 F3: On October 4, 2022, the reporting person was granted a target number of 75,944 RSUs subject to performance and time-based vesting. On February 25, 2025, the Compensation Committee of the issuer determined that based on the issuer's performance between July 2022 and December 2024, 150% of the target number of RSUs vested on performance-based vesting requirements. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 199,440 |
Reported balance
After 2025-02-25 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2025-02-25 · Disposition to issuer · Disposed 113,916 · Balance 199,440 F5: On October 4, 2022, the reporting person was granted a target number of 75,944 RSUs subject to performance and time-based vesting. [On December 31, 2024, the [Compensation Committee] of the issuer determined that based on the issuer's fiscal year 2023 and 2024 performance, 150% of the target number of RSUs vested on performance-based vesting requirements. The 113,916 RSUs had a vesting date of January 6, 2025, subject to continued service]. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. F6: The transaction reflects the cash settlement of 113,916 vested RSUs. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 205,346 |
Reported balance
After 2025-01-26 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2025-01-26 · Grant · Acquired 5,906 · Balance 205,346 F7: On January 26, 2022, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on January 26, 2023 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 5,906 RSUs vested on January 26, 2025. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 202,682 |
Reported balance
After 2025-01-26 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2025-01-26 · Tax withholding · Disposed 2,664 · Balance 202,682 F7: On January 26, 2022, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on January 26, 2023 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 5,906 RSUs vested on January 26, 2025. F8: Shares withheld to satisfy tax withholding obligation arising upon the vesting of RSUs. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 244,023 |
Reported balance
After 2025-01-26 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2025-01-26 · Grant · Acquired 41,341 · Balance 244,023 F9: On January 26, 2022, the reporting person was granted 41,341 RSUs subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 41,341 RSUs vested on January 26, 2025. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 225,400 |
Reported balance
After 2025-01-26 transaction · row 8
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 8 · 2025-01-26 · Tax withholding · Disposed 18,623 · Balance 225,400 F8: Shares withheld to satisfy tax withholding obligation arising upon the vesting of RSUs. F9: On January 26, 2022, the reporting person was granted 41,341 RSUs subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 41,341 RSUs vested on January 26, 2025. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 257,156 |
Reported balance
After 2025-02-13 transaction · row 9
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 9 · 2025-02-13 · Exercise / conversion · Acquired 31,756 · Balance 257,156 F10: On April 26, 2024, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2025 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 31,756 RSUs vested on February 16, 2025. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 242,858 |
Reported balance
After 2025-02-13 transaction · row 10
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 10 · 2025-02-13 · Tax withholding · Disposed 14,298 · Balance 242,858 F8: Shares withheld to satisfy tax withholding obligation arising upon the vesting of RSUs. F10: On April 26, 2024, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2025 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 31,756 RSUs vested on February 16, 2025. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 258,896 |
Reported balance
After 2025-02-16 transaction · row 11
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 11 · 2025-02-16 · Exercise / conversion · Acquired 16,038 · Balance 258,896 F5: On October 4, 2022, the reporting person was granted a target number of 75,944 RSUs subject to performance and time-based vesting. [On December 31, 2024, the [Compensation Committee] of the issuer determined that based on the issuer's fiscal year 2023 and 2024 performance, 150% of the target number of RSUs vested on performance-based vesting requirements. The 113,916 RSUs had a vesting date of January 6, 2025, subject to continued service]. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 242,858 |
Reported balance
After 2025-02-16 transaction · row 12
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 12 · 2025-02-16 · Disposition to issuer · Disposed 16,038 · Balance 242,858 F5: On October 4, 2022, the reporting person was granted a target number of 75,944 RSUs subject to performance and time-based vesting. [On December 31, 2024, the [Compensation Committee] of the issuer determined that based on the issuer's fiscal year 2023 and 2024 performance, 150% of the target number of RSUs vested on performance-based vesting requirements. The 113,916 RSUs had a vesting date of January 6, 2025, subject to continued service]. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. F6: The transaction reflects the cash settlement of 113,916 vested RSUs. F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024. F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 243,927 |
Reported balance
After 2025-03-11 transaction · row 13
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 13 · 2025-03-11 · Exercise / conversion · Acquired 1,069 · Balance 243,927 F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025. |
| Common StockSEC Table I · non-derivative | Direct | 243,444 |
Reported balance
After 2025-03-11 transaction · row 14
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 14 · 2025-03-11 · Tax withholding · Disposed 483 · Balance 243,444 F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025. F8: Shares withheld to satisfy tax withholding obligation arising upon the vesting of RSUs. |
| Common StockSEC Table I · non-derivative | Direct | 266,220 |
Reported balance
After 2025-03-11 transaction · row 15
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 15 · 2025-03-11 · Exercise / conversion · Acquired 22,776 · Balance 266,220 F10: On April 26, 2024, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2025 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 31,756 RSUs vested on February 16, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 255,948 |
Reported balance
After 2025-03-11 transaction · row 16
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 16 · 2025-03-11 · Tax withholding · Disposed 10,272 · Balance 255,948 F8: Shares withheld to satisfy tax withholding obligation arising upon the vesting of RSUs. F10: On April 26, 2024, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2025 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 31,756 RSUs vested on February 16, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 282,050 |
Reported balance
After 2025-03-11 transaction · row 17
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 17 · 2025-03-11 · Grant · Acquired 26,102 · Balance 282,050 F11: On February 16, 2023, the reporting person was granted a target number of 72,171 RSUs subject to performance and time-based vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of a prorated portion of the reporting person's grant, resulting in the reporting person receiving 22,776 shares of the issuer's common stock. |
| Common StockSEC Table I · non-derivative | Direct | 270,277 |
Reported balance
After 2025-03-11 transaction · row 18
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 18 · 2025-03-11 · Tax withholding · Disposed 11,773 · Balance 270,277 F8: Shares withheld to satisfy tax withholding obligation arising upon the vesting of RSUs. F11: On February 16, 2023, the reporting person was granted a target number of 72,171 RSUs subject to performance and time-based vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of a prorated portion of the reporting person's grant, resulting in the reporting person receiving 22,776 shares of the issuer's common stock. |
| Common StockSEC Table I · non-derivative | Direct | 324,082 |
Reported balance
After 2025-03-11 transaction · row 19
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 19 · 2025-03-11 · Grant · Acquired 53,805 · Balance 324,082 F12: On April 26, 2024, the reporting person was granted a target number of 142,904 RSUs subject to performance and time-based vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of a prorated portion of the reporting person's grant, resulting in the reporting person receiving 53,805 shares of the issuer's common stock. |
| Common StockSEC Table I · non-derivative | Direct | 299,847 |
Reported balance
After 2025-03-11 transaction · row 20
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 20 · 2025-03-11 · Tax withholding · Disposed 24,235 · Balance 299,847 F8: Shares withheld to satisfy tax withholding obligation arising upon the vesting of RSUs. F11: On February 16, 2023, the reporting person was granted a target number of 72,171 RSUs subject to performance and time-based vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of a prorated portion of the reporting person's grant, resulting in the reporting person receiving 22,776 shares of the issuer's common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 48,116 |
Reported balance
After 2023-02-16 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2023-02-16 · Grant · Acquired 48,116 · Balance 48,116 F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025. F13: The transaction reflects the re-reporting of the grant of 48,114 RSUs on February 16, 2023 and vesting of 16,038 RSUs on February 16, 2024, incorrectly included in Table I reported on the reporting person's Form 4 filed on March 7, 2023 and February 20, 2024, respectively. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 32,076 |
Reported balance
After 2024-02-16 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2024-02-16 · Exercise / conversion · Disposed 16,038 · Balance 32,076 F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025. F13: The transaction reflects the re-reporting of the grant of 48,114 RSUs on February 16, 2023 and vesting of 16,038 RSUs on February 16, 2024, incorrectly included in Table I reported on the reporting person's Form 4 filed on March 7, 2023 and February 20, 2024, respectively. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 16,038 |
Reported balance
After 2025-02-16 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2025-02-16 · Exercise / conversion · Disposed 16,038 · Balance 16,038 F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-03-11 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2025-03-11 · Exercise / conversion · Disposed 1,069 · Balance 0 F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025. F14: On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of certain unvested restricted stock units that are time-based, which represents a prorated portion of the reporting person's grants as of March 11, 2025. The cancellation of the remaining unvested restricted stock units is reflected as a reduction to the number of derivative securities reported in Column 9. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 95,589 |
Reported balance
After 2024-04-26 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2024-04-26 · Grant · Acquired 95,269 · Balance 95,589 F10: On April 26, 2024, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2025 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 31,756 RSUs vested on February 16, 2025. F15: The transaction reflects the re-reporting of the grant of 95,269 RSUs on April 26, 2024, incorrectly included in Table I reported on the reporting person's Form 4 filed on April 30, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 63,513 |
Reported balance
After 2025-02-13 transaction · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · 2025-02-13 · Exercise / conversion · Disposed 31,756 · Balance 63,513 F10: On April 26, 2024, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2025 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 31,756 RSUs vested on February 16, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-13 transaction · row 27
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 27 · 2025-02-13 · Exercise / conversion · Disposed 22,776 · Balance 0 F10: On April 26, 2024, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2025 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 31,756 RSUs vested on February 16, 2025. F14: On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of certain unvested restricted stock units that are time-based, which represents a prorated portion of the reporting person's grants as of March 11, 2025. The cancellation of the remaining unvested restricted stock units is reflected as a reduction to the number of derivative securities reported in Column 9. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 113,916 |
Reported balance
After 2025-02-25 transaction · row 28
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 28 · 2025-02-25 · Grant · Acquired 113,916 · Balance 113,916 F5: On October 4, 2022, the reporting person was granted a target number of 75,944 RSUs subject to performance and time-based vesting. [On December 31, 2024, the [Compensation Committee] of the issuer determined that based on the issuer's fiscal year 2023 and 2024 performance, 150% of the target number of RSUs vested on performance-based vesting requirements. The 113,916 RSUs had a vesting date of January 6, 2025, subject to continued service]. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-25 transaction · row 29
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 29 · 2025-02-25 · Exercise / conversion · Disposed 113,916 · Balance 0 F5: On October 4, 2022, the reporting person was granted a target number of 75,944 RSUs subject to performance and time-based vesting. [On December 31, 2024, the [Compensation Committee] of the issuer determined that based on the issuer's fiscal year 2023 and 2024 performance, 150% of the target number of RSUs vested on performance-based vesting requirements. The 113,916 RSUs had a vesting date of January 6, 2025, subject to continued service]. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 16, 2023, the reporting person was granted 48,114 restricted stock units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2024 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 16,038 RSUs vested on each of February 16, 2024 and 2025. The transaction reflects the cash settlement of 16,038 vested RSUs on each of February 16, 2024 and 2025.
F2: The reporting person's number of shares of common stock owned was previously overstated by 84,541 shares due to a number of RSUs that should have been reported in Table II instead of Table I on the reporting person's Form 4 documents filed on March 7, 2023 and April 30, 2024.
F3: On October 4, 2022, the reporting person was granted a target number of 75,944 RSUs subject to performance and time-based vesting. On February 25, 2025, the Compensation Committee of the issuer determined that based on the issuer's performance between July 2022 and December 2024, 150% of the target number of RSUs vested on performance-based vesting requirements. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting.
F4: The amount of securities beneficially owned from this transaction reflects the sale of 12,000 shares of common stock of the issuer previously disclosed on the reporting person's Form 4 filed on August 16, 2024.
F5: On October 4, 2022, the reporting person was granted a target number of 75,944 RSUs subject to performance and time-based vesting. [On December 31, 2024, the [Compensation Committee] of the issuer determined that based on the issuer's fiscal year 2023 and 2024 performance, 150% of the target number of RSUs vested on performance-based vesting requirements. The 113,916 RSUs had a vesting date of January 6, 2025, subject to continued service]. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting.
F6: The transaction reflects the cash settlement of 113,916 vested RSUs.
F7: On January 26, 2022, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on January 26, 2023 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 5,906 RSUs vested on January 26, 2025.
F8: Shares withheld to satisfy tax withholding obligation arising upon the vesting of RSUs.
F9: On January 26, 2022, the reporting person was granted 41,341 RSUs subject to time vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 41,341 RSUs vested on January 26, 2025.
F10: On April 26, 2024, the reporting person was granted 95,269 RSUs subject to time vesting. Such RSUs vest in three equal annual installments beginning on February 16, 2025 and each anniversary thereafter. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. 31,756 RSUs vested on February 16, 2025.
F11: On February 16, 2023, the reporting person was granted a target number of 72,171 RSUs subject to performance and time-based vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of a prorated portion of the reporting person's grant, resulting in the reporting person receiving 22,776 shares of the issuer's common stock.
F12: On April 26, 2024, the reporting person was granted a target number of 142,904 RSUs subject to performance and time-based vesting. Each RSU represents a right to receive one share of the common stock of the issuer and/or cash upon vesting. On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of a prorated portion of the reporting person's grant, resulting in the reporting person receiving 53,805 shares of the issuer's common stock.
F13: The transaction reflects the re-reporting of the grant of 48,114 RSUs on February 16, 2023 and vesting of 16,038 RSUs on February 16, 2024, incorrectly included in Table I reported on the reporting person's Form 4 filed on March 7, 2023 and February 20, 2024, respectively.
F14: On March 11, 2025, upon the resignation by the reporting person as the issuer's President and Chief Executive Officer, and director, the issuer accelerated the vesting of certain unvested restricted stock units that are time-based, which represents a prorated portion of the reporting person's grants as of March 11, 2025. The cancellation of the remaining unvested restricted stock units is reflected as a reduction to the number of derivative securities reported in Column 9.
F15: The transaction reflects the re-reporting of the grant of 95,269 RSUs on April 26, 2024, incorrectly included in Table I reported on the reporting person's Form 4 filed on April 30, 2024.
Neenah Inc
Report date July 06, 2022 · Filed July 29, 2022
Section 16 reporting ended · disclosed 2022-07-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2022-07-06 · Disposition to issuer · Disposed 14,427 · Balance 0 F1: These shares of common stock were disposed of pursuant to the Agreement and Plan of Merger, dated as of March 28, 2022 (the "Merger Agreement") by and among Neenah, Inc. ("Neenah"), Samurai Warrior Merger Sub, Inc. and Mativ Holdings, Inc. (f/k/a Schweitzer-Mauduit International, Inc., "Mativ") in exchange for shares of Mativ common stock, at a rate of 1.358 shares of Mativ common stock for each share of Neenah common stock. The closing price of Mativ common stock on the New York Stock Exchange on July 6, 2022, the effective date of the merger (the "Effective Date"), was $22.41. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2022-07-06 · Disposition to issuer · Disposed 22,803 · Balance 0 F2: These shares were subject to Neenah restricted stock units, which, pursuant to the Merger Agreement on the Effective Date, automatically converted into Mativ restricted stock units in respect of that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to the Neenah restricted stock unit award immediately prior to the Effective Time and 1.358. Each such Mativ restricted stock unit award is subject to the same terms and conditions as applied to the corresponding Neenah restricted stock unit award immediately prior to the Effective Time. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-07-06 · Disposition to issuer · Disposed 67,550 · Balance 0 F3: Pursuant to the Merger Agreement, on the Effective Date, these Neenah performance share units automatically converted into Mativ restricted stock unit awards with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah performance share units immediately prior to the Effective Time and 1.358 and are convertible into shares of Mativ common stock on a one-for-one basis on the applicable vesting dates. F4: Each such Mativ restricted stock unit award is scheduled to cliff vest, subject to continued service, on the last day of the originally scheduled performance period, but subject to earlier payment and vesting in accordance with the applicable Neenah performance share award agreement. Otherwise, each such Mativ restricted stock unit award is subject to the same terms and conditions as applied to the corresponding Neenah performance share award immediately prior to the Effective Time. F5: The performance share units do not have an expiration date. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Expires 2024-01-27 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-07-06 · Disposition to issuer · Disposed 4,370 · Balance 0 F7: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah stock appreciation rights immediately prior to the Effective Time and 1.358. F6: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that numbers of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such stock appreciation rights immediately prior to the Effective Time and 1.358; provided, however, that the exercise price and the number of shares of SWM Common Stock will be determined in a manner consistent with the requirements of Section 409A of the Code. F8: The Stock Appreciation Rights are fully vested. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Expires 2026-01-25 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-07-06 · Disposition to issuer · Disposed 5,996 · Balance 0 F7: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah stock appreciation rights immediately prior to the Effective Time and 1.358. F6: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that numbers of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such stock appreciation rights immediately prior to the Effective Time and 1.358; provided, however, that the exercise price and the number of shares of SWM Common Stock will be determined in a manner consistent with the requirements of Section 409A of the Code. F8: The Stock Appreciation Rights are fully vested. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Expires 2023-01-28 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-07-06 · Disposition to issuer · Disposed 4,900 · Balance 0 F7: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah stock appreciation rights immediately prior to the Effective Time and 1.358. F6: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that numbers of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such stock appreciation rights immediately prior to the Effective Time and 1.358; provided, however, that the exercise price and the number of shares of SWM Common Stock will be determined in a manner consistent with the requirements of Section 409A of the Code. F8: The Stock Appreciation Rights are fully vested. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Expires 2027-01-29 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-07-06 · Disposition to issuer · Disposed 7,085 · Balance 0 F7: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah stock appreciation rights immediately prior to the Effective Time and 1.358. F6: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that numbers of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such stock appreciation rights immediately prior to the Effective Time and 1.358; provided, however, that the exercise price and the number of shares of SWM Common Stock will be determined in a manner consistent with the requirements of Section 409A of the Code. F8: The Stock Appreciation Rights are fully vested. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Expires 2025-01-26 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-07-06 · Disposition to issuer · Disposed 4,380 · Balance 0 F7: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah stock appreciation rights immediately prior to the Effective Time and 1.358. F6: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that numbers of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such stock appreciation rights immediately prior to the Effective Time and 1.358; provided, however, that the exercise price and the number of shares of SWM Common Stock will be determined in a manner consistent with the requirements of Section 409A of the Code. F8: The Stock Appreciation Rights are fully vested. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Expires 2028-01-30 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-07-06 · Disposition to issuer · Disposed 7,186 · Balance 0 F7: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah stock appreciation rights immediately prior to the Effective Time and 1.358. F6: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that numbers of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such stock appreciation rights immediately prior to the Effective Time and 1.358; provided, however, that the exercise price and the number of shares of SWM Common Stock will be determined in a manner consistent with the requirements of Section 409A of the Code. F8: The Stock Appreciation Rights are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock were disposed of pursuant to the Agreement and Plan of Merger, dated as of March 28, 2022 (the "Merger Agreement") by and among Neenah, Inc. ("Neenah"), Samurai Warrior Merger Sub, Inc. and Mativ Holdings, Inc. (f/k/a Schweitzer-Mauduit International, Inc., "Mativ") in exchange for shares of Mativ common stock, at a rate of 1.358 shares of Mativ common stock for each share of Neenah common stock. The closing price of Mativ common stock on the New York Stock Exchange on July 6, 2022, the effective date of the merger (the "Effective Date"), was $22.41.
F2: These shares were subject to Neenah restricted stock units, which, pursuant to the Merger Agreement on the Effective Date, automatically converted into Mativ restricted stock units in respect of that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to the Neenah restricted stock unit award immediately prior to the Effective Time and 1.358. Each such Mativ restricted stock unit award is subject to the same terms and conditions as applied to the corresponding Neenah restricted stock unit award immediately prior to the Effective Time.
F3: Pursuant to the Merger Agreement, on the Effective Date, these Neenah performance share units automatically converted into Mativ restricted stock unit awards with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah performance share units immediately prior to the Effective Time and 1.358 and are convertible into shares of Mativ common stock on a one-for-one basis on the applicable vesting dates.
F4: Each such Mativ restricted stock unit award is scheduled to cliff vest, subject to continued service, on the last day of the originally scheduled performance period, but subject to earlier payment and vesting in accordance with the applicable Neenah performance share award agreement. Otherwise, each such Mativ restricted stock unit award is subject to the same terms and conditions as applied to the corresponding Neenah performance share award immediately prior to the Effective Time.
F5: The performance share units do not have an expiration date.
F6: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that numbers of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such stock appreciation rights immediately prior to the Effective Time and 1.358; provided, however, that the exercise price and the number of shares of SWM Common Stock will be determined in a manner consistent with the requirements of Section 409A of the Code.
F7: Pursuant to the Merger Agreement, on the Effective Date, these Neenah stock appreciation rights automatically converted into Mativ stock appreciation rights with respect to that number of shares of Mativ common stock (rounded down to the nearest whole share) equal to the product of the number of shares of Neenah common stock subject to such Neenah stock appreciation rights immediately prior to the Effective Time and 1.358.
F8: The Stock Appreciation Rights are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2018 Filed Feb 1, 2018 13:05 UTC | Neenah Inc NP · Entity 125047 | GrantStock Appreciation Rights · Derivative | 7,186 | $0.00 Strike: $93.35 | $0.00 |
DisclosureSEC source: 0001296435-18-000036 · wf-form4_151750828776400.xml · derivative · entry 2 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,372 Underlying: Common stock · 7,186 shares Expires 2028-01-29 F3 · derivative.exercise_date: The stock appreciation rights vest in increments of one-third on 01/30/2019, 01/30/2020, and 01/30/2021. Read SEC document |
| January 30, 2018 Filed Feb 1, 2018 13:05 UTC | Neenah Inc NP · Entity 125047 | GrantCommon stock · Derivative | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001296435-18-000036 · wf-form4_151750828776400.xml · derivative · entry 1 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: Common stock · 2,700 shares Expires not disclosed F1 · derivative.exercise_price: The units are convertible to common stock on a one-for-one basis. F2 · derivative.expiration_date: The units do not have an expiration date. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 14:03 UTC | Neenah Inc NP · Entity 125047 | Exercise / conversionPerformance Share Unit · Derivative | 2,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001296435-18-000005 · wf-form4_151500617513535.xml · derivative · entry 3 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,760 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The units are convertible to common stock on a one-for-one basis. F3 · derivative.expiration_date: The units do not have an expiration date. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 14:03 UTC | Neenah Inc NP · Entity 125047 | Tax withholdingCommon stock | 1,947 | $90.65 | $176,495.55 |
DisclosureSEC source: 0001296435-18-000005 · wf-form4_151500617513535.xml · nonDerivative · entry 2 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,472 F1 · shares: Number of shares withheld by the company to pay taxes upon the vesting of 4,030 restricted shares on 1/3/2018. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 14:03 UTC | Neenah Inc NP · Entity 125047 | Exercise / conversionCommon stock | 4,030 | $90.65 | $365,319.50 |
DisclosureSEC source: 0001296435-18-000005 · wf-form4_151500617513535.xml · nonDerivative · entry 1 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Number of shares withheld by the company to pay taxes upon the vesting of 4,030 restricted shares on 1/3/2018. Read SEC document |
| August 29, 2017 Filed Sep 7, 2017 10:38 UTC | Neenah Inc NP · Entity 125047 | GiftCommon stock | 400 | $62.43 | $24,972.00 |
DisclosureSEC source: 0001296435-17-000137 · wf-form4_150479508487274.xml · nonDerivative · entry 1 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,389 Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 10:32 UTC | Neenah Inc NP · Entity 125047 | SaleCommon stock | 2,000 | $76.71 | $153,420.00 |
DisclosureSEC source: 0001296435-17-000132 · wf-form4_150401711772183.xml · nonDerivative · entry 1 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,789 Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 08:39 UTC | Neenah Inc NP · Entity 125047 | Exercise / conversionStock Appreciation Rights · Derivative | 1,219 | $80.65 Strike: $19.25 | $98,312.35 |
DisclosureSEC source: 0001296435-17-000104 · wf-form4_149744392758152.xml · derivative · entry 3 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382 Underlying: Common stock · 1,219 shares Expires 2021-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock Appreciation Rights are fully vested. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 08:39 UTC | Neenah Inc NP · Entity 125047 | SaleCommon stock | 1,219 | $80.65 | $98,312.35 |
DisclosureSEC source: 0001296435-17-000104 · wf-form4_149744392758152.xml · nonDerivative · entry 2 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,392 Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 08:39 UTC | Neenah Inc NP · Entity 125047 | Exercise / conversionCommon stock | 1,219 | $19.25 | $23,465.75 |
DisclosureSEC source: 0001296435-17-000104 · wf-form4_149744392758152.xml · nonDerivative · entry 1 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 14:33 UTC | Neenah Inc NP · Entity 125047 | GrantStock Appreciation Rights · Derivative | 7,085 | $0.00 Strike: $82.15 | $0.00 |
DisclosureSEC source: 0001296435-17-000033 · wf-form4_148597758763203.xml · derivative · entry 2 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,085 Underlying: Common Sock · 7,085 shares Expires 2027-01-29 F3 · derivative.exercise_date: The stock appreciation rights vest in increments of one-third on 01/30/2018, 01/30/2019, and 01/30/2020. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 14:33 UTC | Neenah Inc NP · Entity 125047 | GrantPerformance Share Units · Derivative | 2,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001296435-17-000033 · wf-form4_148597758763203.xml · derivative · entry 1 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,727 Underlying: Common Sock · 2,727 shares Expires not disclosed F1 · derivative.exercise_price: The units are convertible to common stock on a one-for-one basis. F2 · derivative.expiration_date: The units do not have an expiration date. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 11:05 UTC | Neenah Inc NP · Entity 125047 | Tax withholdingCommon stock | 3,177 | $85.20 | $270,680.40 |
DisclosureSEC source: 0001296435-17-000008 · wf-form4_148363233169199.xml · nonDerivative · entry 1 Schertell Julie · CIK 0001509525 · SVP, President FP&P. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,392 F1 · shares: Number of shares withheld by the company to pay taxes upon the vesting of 6,569 restricted shares on 1/3/2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.